UCB Stem Cell: New hope for cancer patients
148 Pages
Report

Published Date: 21-Jan-2014
Description
Global stem cell market is dominating the healthcare industry with its
reliable and cost effective methods of ...
Table of Content
1. Introduction
2. Executive Summary
3. Global UCB stem cell Market Overview
4. Key findings
5. Market Dy...
Introduction
Scope of the Report

Objectives

Key Benefits

Key Deliverables

Key Audiences
Key Findings

Minimal invasive
techniques of
collection and
transferring
Reimbursement
and insurance
issues in
storage
Eff...
Mar ket Dynamics

Market
Dynamics

Key Market
Drivers

Minimal
invasive
methods

Treatment
on chronic
diseases

Cost
effec...
Market by Storage Service

Market by Storage
Service

Public cord blood
banks

Private cord blood
banks
SINGAPORE CORD BLOOD BANK INVENTORY AND TRANSPLANT (2005-2013)
Singapore cord blood has increased in number of cord blood ...
Market by Therapeutics

Diabetes
Cancer/
Oncology
diseases

Blood diseases
Market by
Therapeutics

Other
diseases
Metaboli...
GROWTH IN DISEASE TREATED VS. CLINICAL TRIALS
(2008-2012)
According to research conducted by BioInformant Worldwide on the...
Market by Application

• Autologous transplant
• Allogeneic
transplant

Stem Cell
Transplant

Regenerative
Medicine
• Rege...
Top Market Players

 Cytori Therapeutics Inc.

 Advanced Cell Technology, Inc. (USA)
 CALIFORNIA STEM CELL
 Osiris The...
Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market S...
http://www.alliedmarketresearch.com/ste
m-cell-umbilical-cord-blood-UCB-market
Upcoming SlideShare
Loading in …5
×

Global stem cell umbilical cord blood (ucb) market size, share, global trends, analysis, opportunities, growth, intelligence and forecast, 2012 - 2020

804 views
536 views

Published on

Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Umbilical cord blood stem cells are one of the potential segments of stem cell market for growth in future.

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
804
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global stem cell umbilical cord blood (ucb) market size, share, global trends, analysis, opportunities, growth, intelligence and forecast, 2012 - 2020

  1. 1. UCB Stem Cell: New hope for cancer patients
  2. 2. 148 Pages Report Published Date: 21-Jan-2014
  3. 3. Description Global stem cell market is dominating the healthcare industry with its reliable and cost effective methods of treatments with fewer side effects. Umbilical cord blood stem cells are one of the potential segments of stem cell market for growth in future. Cord blood has huge potential to treat chronic diseases such as cancer, diabetes, blood disease immune diseases, etc. More than 80 genetic diseases were treated with cord blood in current scenario. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization. This is therefore, compelling the market players to formulate market based strategies. Cord blood stem cells are stored in controlled conditions due to its lower volume higher cell count feature. Storage service market is expected grow at 33.4% CAGR from 2013-2020.
  4. 4. Table of Content 1. Introduction 2. Executive Summary 3. Global UCB stem cell Market Overview 4. Key findings 5. Market Dynamics 6. Global UCB Stem Cell Market by Storage Service 7. Global UCB Stem Cell Market by Therapeutics 8. Global UCB Stem Cell Market by Application 9. Geography Analysis 10. Corporate Profiles and Analysis
  5. 5. Introduction Scope of the Report Objectives Key Benefits Key Deliverables Key Audiences
  6. 6. Key Findings Minimal invasive techniques of collection and transferring Reimbursement and insurance issues in storage Efficient transferring during treatment Efficient extraction of cord blood Storage service for maintaining viability Top ten factors impacting UCB stem cell market Positive engraftment of tissue Government regulation and intervention Ethical issues in storage and application Cost of treatment Availability of treatment and sample
  7. 7. Mar ket Dynamics Market Dynamics Key Market Drivers Minimal invasive methods Treatment on chronic diseases Cost effective therapy and storage Market Restraints Easy extraction methods Intact genetic structure Government regulations and intervention Legal and ethical issues during collection Availability of right type of donor Higher cost of therapies
  8. 8. Market by Storage Service Market by Storage Service Public cord blood banks Private cord blood banks
  9. 9. SINGAPORE CORD BLOOD BANK INVENTORY AND TRANSPLANT (2005-2013) Singapore cord blood has increased in number of cord blood inventory due to increase in government policies and awareness program conducted for cord blood donation. Practical application of this stem cell transplant is also increased with increase in commercialization of stem cell transplant and other transplant application. Market for cord blood stem cell transplant is expecting more advantage that is competitive by providing cost effective therapies in future.
  10. 10. Market by Therapeutics Diabetes Cancer/ Oncology diseases Blood diseases Market by Therapeutics Other diseases Metabolic Disorders Immune Disorders
  11. 11. GROWTH IN DISEASE TREATED VS. CLINICAL TRIALS (2008-2012) According to research conducted by BioInformant Worldwide on the stem cell industry, it is observed that frequency of clinical trials for cord blood research is increased by 144% during past five years. According to clinical trials.gov. ,there were 78 clinical trials conducted for cord blood stem cell in 2008 compared to 191 in 2012. This will shows the increased percentage of cord blood clinical trials by more than 145%. 2008 2009 Disease Treated 2010 2011 Cord blood clinical trials 2012
  12. 12. Market by Application • Autologous transplant • Allogeneic transplant Stem Cell Transplant Regenerative Medicine • Regenerative Medicine • Transplant Medicine Transplant Medicine Others •Blood Transfusion •Cell Based Genetics
  13. 13. Top Market Players  Cytori Therapeutics Inc.  Advanced Cell Technology, Inc. (USA)  CALIFORNIA STEM CELL  Osiris Therapeutics  NeoStem Inc.  Geron Corporation  Opexa Therapeutics, Inc.  Athersys, Inc.  Pluristem Therapeutics Inc.  Mesoblast Limited
  14. 14. Your feedback is important to us What would you like to know more about this Study ?  Global Industry Analysis  Market Size  Market Share  Market Trends Opportunities and Forecast Please inform us on : http://www.alliedmarketresearch.com/contact-us
  15. 15. http://www.alliedmarketresearch.com/ste m-cell-umbilical-cord-blood-UCB-market

×